Form 8-K - Current report:
SEC Accession No. 0001013762-25-000999
Filing Date
2025-03-21
Accepted
2025-03-21 16:15:08
Documents
14
Period of Report
2025-03-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0235166-8k_adial.htm   iXBRL 8-K 27305
2 EMPLOYMENT AGREEMENT BETWEEN ADIAL PHARMACEUTICALS, INC. AND TONY GOODMAN, EFFEC ea023516601ex10-1_adial.htm EX-10.1 179789
  Complete submission text file 0001013762-25-000999.txt   425890

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE adil-20250320.xsd EX-101.SCH 3006
4 XBRL LABEL FILE adil-20250320_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE adil-20250320_pre.xml EX-101.PRE 22353
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0235166-8k_adial_htm.xml XML 3657
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

EIN.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38323 | Film No.: 25760671
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)